Bavarian Nordic (OTCMKTS:BVNRY) Shares Pass Below 50-Day Moving Average – Time to Sell?

Bavarian Nordic (OTCMKTS:BVNRY) shares crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $9.54 and traded as low as $9.07. Bavarian Nordic shares last traded at $9.33, with a volume of 4,138 shares.

Bavarian Nordic Price Performance

The stock has a market capitalization of $2.22 billion, a price-to-earnings ratio of 12.28 and a beta of 1.20. The business’s 50-day simple moving average is $9.54 and its two-hundred day simple moving average is $9.86.

Bavarian Nordic (OTCMKTS:BVNRY) last released its quarterly earnings data on Wednesday, May 13th. The company reported $0.01 earnings per share (EPS) for the quarter. Bavarian Nordic had a net margin of 19.74% and a return on equity of 9.32%. The company had revenue of $165.70 million during the quarter.

Bavarian Nordic Company Profile

Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.

The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.